Sepsis: Current dogma and new perspectives

Immunity

Volumn 40, Issue 4, 2014, Pages 463-475

  Deutschman, Clifford S ^a   Tracey, Kevin J ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ENDOTHELIUM; ENERGY METABOLISM; EPITHELIUM; HUMANS; INFLAMMATION MEDIATORS; MULTIPLE ORGAN FAILURE; NEUROIMMUNOMODULATION; SEPSIS; SYNAPTIC TRANSMISSION;

EID: 84898684570     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.04.001     Document Type: Review

References (112)

1. Ahmad S., Tejuja A., Newman K.D., Zarychanski R., Seely A.J. Clinical review: a review and analysis of heart rate variability and the diagnosis and prognosis of infection. Crit. Care 2009, 13:232.
2. Andersson U., Tracey K.J. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 2011, 29:139-162.
3. Andersson U., Tracey K.J. Reflex principles of immunological homeostasis. Annu. Rev. Immunol. 2012, 30:313-335.
4. Andersson U., Tracey K.J. Neural reflexes in inflammation and immunity. J.Exp. Med. 2012, 209:1057-1068.
5. Andersson U., Tracey K.J. A new approach to rheumatoid arthritis: treating inflammation with computerized nerve stimulation. Cerebrum 2012, 2012:3.
6. Angus D.C., van der Poll T. Severe sepsis and septic shock. N.Engl. J. Med. 2013, 369:840-851.
7. Angus D.C., Yang L., Kong L., Kellum J.A., Delude R.L., Tracey K.J., Weissfeld L. Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit. Care Med. 2007, 35:1061-1067. GenIMS Investigators.
8. Antoine D.J., Harris H.E., Andersson U., Tracey K.J., Bianchi M.E. A systematic nomenclature for the redox states of high mobility group box (HMGB) proteins. Mol. Med. 2014, Published online February 10, 2014. 10.2119/molmed.2014.00022.
9. Arima Y., Harada M., Kamimura D., Park J.-H., Kawano F., Yull F.E., Kawamoto T., Iwakura Y., Betz U.A., Márquez G., et al. Regional neural activation defines a gateway for autoreactive Tcells to cross the blood-brain barrier. Cell 2012, 148:447-457.
10. Barnaby D., Ferrick K., Kaplan D.T., Shah S., Bijur P., Gallagher E.J. Heart rate variability in emergency department patients with sepsis. Acad. Emerg. Med. 2002, 9:661-670.
11. Bernik T.R., Friedman S.G., Ochani M., DiRaimo R., Ulloa L., Yang H., Sudan S., Czura C.J., Ivanova S.M., Tracey K.J. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J.Exp. Med. 2002, 195:781-788.
12. Binshtok A.M., Wang H., Zimmermann K., Amaya F., Vardeh D., Shi L., Brenner G.J., Ji R.-R., Bean B.P., Woolf C.J., Samad T.A. Nociceptors are interleukin-1beta sensors. J.Neurosci. 2008, 28:14062-14073.
13. Bone R.C., Sibbald W.J., Sprung C.L. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992, 101:1481-1483.
14. Boomer J.S., To K., Chang K.C., Takasu O., Osborne D.F., Walton A.H., Bricker T.L., Jarman S.D., Kreisel D., Krupnick A.S., et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011, 306:2594-2605.
15. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Wang H., Abumrad N., Eaton J.W., Tracey K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
16. Bosmann M., Ward P.A. The inflammatory response in sepsis. Trends Immunol. 2013, 34:129-136.
17. Brealey D., Brand M., Hargreaves I., Heales S., Land J., Smolenski R., Davies N.A., Cooper C.E., Singer M. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002, 360:219-223.
18. Buchan C.A., Bravi A., Seely A.J.E. Variability analysis and the diagnosis, management, and treatment of sepsis. Curr. Infect. Dis. Rep. 2012, 14:512-521.
19. Buchman T.G. The community of the self. Nature 2002, 420:246-251.
20. Cavaillon J.-M., Adib-Conquy M. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit. Care 2006, 10:233.
21. Chan A.C., Carter P.J. Therapeutic antibodies for autoimmunity and inflammation. Nat. Rev. Immunol. 2010, 10:301-316.
22. Chavan S.S., Huerta P.T., Robbiati S., Valdes-Ferrer S.I., Ochani M., Dancho M., Frankfurt M., Volpe B.T., Tracey K.J., Diamond B. HMGB1 mediates cognitive impairment in sepsis survivors. Mol. Med. 2012, 18:930-937.
23. Chen W.-L., Kuo C.-D. Characteristics of heart rate variability can predict impending septic shock in emergency department patients with sepsis. Acad. Emerg. Med. 2007, 14:392-397.
24. Chiu I.M., von Hehn C.A., Woolf C.J. Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat. Neurosci. 2012, 15:1063-1067.
25. Chiu I.M.I., Heesters B.A., Ghasemlou N., Von Hehn C.A., Zhao F., Tran J., Wainger B., Strominger A., Muralidharan S., Horswill A.R., et al. Bacteria activate sensory neurons that modulate pain and inflammation. Nature 2013, 501:52-57.
26. Dwyer, J. (2012). One Boy's Death Moves State to Action to Prevent. New York Times. A25.
27. Felmet K.A., Hall M.W., Clark R.S.B., Jaffe R., Carcillo J.A. Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J.Immunol. 2005, 174:3765-3772.
28. Figueiredo N., Chora A., Raquel H., Pejanovic N., Pereira P., Hartleben B., Neves-Costa A., Moita C., Pedroso D., Pinto A., et al. Anthracyclines induce DNA damage response-mediated protection against severe sepsis. Immunity 2013, 39:874-884.
29. Frasure-Smith N., Lespérance F., Irwin M.R., Talajic M., Pollock B.G. The relationships among heart rate variability, inflammatory markers and depression in coronary heart disease patients. Brain Behav. Immun. 2009, 23:1140-1147.
30. Goehler L.E., Relton J.K., Dripps D., Kiechle R., Tartaglia N., Maier S.F., Watkins L.R. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res. Bull. 1997, 43:357-364.
31. Gomez H., Ince C., De Backer D., Pickkers P., Payen D., Hotchkiss J., Kellum J.A. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 2014, 41:3-11.
32. Haden D.W., Suliman H.B., Carraway M.S., Welty-Wolf K.E., Ali A.S., Shitara H., Yonekawa H., Piantadosi C.A. Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis. Am. J. Respir. Crit. Care Med. 2007, 176:768-777.
33. Haneklaus M., O'Neill L.A., Coll R.C. Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments. Curr. Opin. Immunol. 2013, 25:40-45.
34. Inoue S., Suzuki-Utsunomiya K., Okada Y., Taira T., Iida Y., Miura N., Tsuji T., Yamagiwa T., Morita S., Chiba T., et al. Reduction of immunocompetent Tcells followed by prolonged lymphopenia in severe sepsis in the elderly. Crit. Care Med. 2013, 41:810-819.
35. Iskander K.N., Osuchowski M.F., Stearns-Kurosawa D.J., Kurosawa S., Stepien D., Valentine C., Remick D.G. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol. Rev. 2013, 93:1247-1288.
36. Iwashyna T.J., Ely E.W., Smith D.M., Langa K.M. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 2010, 304:1787-1794.
37. Kaukonen K.M., Bailey M., Suzuki S., Pilcher D., Bellomo R. Mortality Related to Severe Sepsis and Septic Shock Among Critically Ill Patients in Australia and New Zealand, 2000-2012. J.Am. Med. Assoc. 2014, Published online March 18, 2014. 10.1001/jama.2014.2637.
38. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
39. Kayagaki N., Warming S., Lamkanfi M., Vande Walle L., Louie S., Dong J., Newton K., Qu Y., Liu J., Heldens S., et al. Non-canonical inflammasome activation targets caspase-11. Nature 2011, 479:117-121.
40. Kumar V., Sharma A. Is neuroimmunomodulation a future therapeutic approach for sepsis?. Int. Immunopharmacol. 2010, 10:9-17.
41. Lamkanfi M., Sarkar A., Vande Walle L., Vitari A.C., Amer A.O., Wewers M.D., Tracey K.J., Kanneganti T.-D., Dixit V.M. Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J.Immunol. 2010, 185:4385-4392.
42. Lehrer P., Karavidas M.K., Lu S.-E., Coyle S.M., Oikawa L.O., Macor M., Calvano S.E., Lowry S.F. Voluntarily produced increases in heart rate variability modulate autonomic effects of endotoxin induced systemic inflammation: an exploratory study. Appl. Psychophysiol. Biofeedback 2010, 35:303-315.
43. Levy R.J., Deutschman C.S. Cytochrome c oxidase dysfunction in sepsis. Crit. Care Med. 2007, 35(Suppl):S468-S475.
44. Liu S., Stolz D.B., Sappington P.L., Macias C.A., Killeen M.E., Tenhunen J.J., Delude R.L., Fink M.P. HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers. Am. J. Physiol. Cell Physiol. 2006, 290:C990-C999.
45. Liu T., Jiang C.-Y., Fujita T., Luo S.-W., Kumamoto E. Enhancement by interleukin-1β of AMPA and NMDA receptor-mediated currents in adult rat spinal superficial dorsal horn neurons. Mol. Pain 2013, 9:16.
46. Lu B., Nakamura T., Inouye K., Li J., Tang Y., Lundbäck P., Valdes-Ferrer S.I., Olofsson P.S., Kalb T., Roth J., et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 2012, 488:670-674.
47. Lu B., Wang H., Andersson U., Tracey K.J. Regulation of HMGB1 release by inflammasomes. Protein Cell 2013, 4:163-167.
48. Lukewich M.K., Rogers R.C., Lomax A.E. Divergent neuroendocrine responses to localized and systemic inflammation. Semin. Immunol. 2014, Published online January 30, 2014. 10.1016/j.smim.2014.01.004.
49. Ma S.-F., Xie L., Pino-Yanes M., Sammani S., Wade M.S., Letsiou E., Siegler J., Wang T., Infusino G., Kittles R.A., et al. Type 2 deiodinase and host responses of sepsis and acute lung injury. Am. J. Respir. Cell Mol. Biol. 2011, 45:1203-1211.
50. Marshall J.C. Sepsis: rethinking the approach to clinical research. J.Leukoc. Biol. 2008, 83:471-482.
51. McGettrick A.F., O'Neill L.A. How metabolism generates signals during innate immunity and inflammation. J.Biol. Chem. 2013, 288:22893-22898.
52. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell 2010, 140:771-776.
53. Medzhitov R., Schneider D.S., Soares M.P. Disease tolerance as a defense strategy. Science 2012, 335:936-941.
54. Meisel C., Schefold J.C., Pschowski R., Baumann T., Hetzger K., Gregor J., Weber-Carstens S., Hasper D., Keh D., Zuckermann H., et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am. J. Respir. Crit. Care Med. 2009, 180:640-648.
55. Monneret G., Venet F., Pachot A., Lepape A. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol. Med. 2008, 14:64-78.
56. Motagally M.A., Lukewich M.K., Chisholm S.P., Neshat S., Lomax A.E. Tumour necrosis factor alpha activates nuclear factor kappaB signalling to reduce N-type voltage-gated Ca2+ current in postganglionic sympathetic neurons. J.Physiol. 2009, 587:2623-2634.
57. Motagally M.A., Neshat S., Lomax A.E. Inhibition of sympathetic N-type voltage-gated Ca2+ current underlies the reduction in norepinephrine release during colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G1077-G1084.
58. Nakahira K., Haspel J.A., Rathinam V.A.K., Lee S.-J., Dolinay T., Lam H.C., Englert J.A., Rabinovitch M., Cernadas M., Kim H.P., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 2011, 12:222-230.
59. Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140:871-882.
60. Nierhaus A., Montag B., Timmler N., Frings D.P., Gutensohn K., Jung R., Schneider C.G., Pothmann W., Brassel A.K., Schulte Am Esch J. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med. 2003, 29:646-651.
61. Niijima A. The afferent discharges from sensors for interleukin 1 beta in the hepatoportal system in the anesthetized rat. J.Auton. Nerv. Syst. 1996, 61:287-291.
62. Niijima A., Hori T., Aou S., Oomura Y. The effects of interleukin-1 beta on the activity of adrenal, splenic and renal sympathetic nerves in the rat. J.Auton. Nerv. Syst. 1991, 36:183-192.
63. O'Neill L.A., Golenbock D., Bowie A.G. The history of Toll-like receptors - redefining innate immunity. Nat. Rev. Immunol. 2013, 13:453-460.
64. Peruchi B.B., Petronilho F., Rojas H.A., Constantino L., Mina F., Vuolo F., Cardoso M.R., Gonçalves C.L., Rezin G.T., Streck E.L., Dal-Pizzol F. Skeletal muscle electron transport chain dysfunction after sepsis in rats. J.Surg. Res. 2011, 167:e333-e338.
65. Qin S., Wang H., Yuan R., Li H., Ochani M., Ochani K., Rosas-Ballina M., Czura C.J., Huston J.M., Miller E., et al. Role of HMGB1 in apoptosis-mediated sepsis lethality. J.Exp. Med. 2006, 203:1637-1642.
66. Rao D.A., Tracey K.J., Pober J.S. IL-1alpha and IL-1beta are endogenous mediators linking cell injury to the adaptive alloimmune response. J.Immunol. 2007, 179:6536-6546.
67. Rosas-Ballina M., Ochani M., Parrish W.R., Ochani K., Harris Y.T., Huston J.M., Chavan S., Tracey K.J. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc. Natl. Acad. Sci. USA 2008, 105:11008-11013.
68. Rosas-Ballina M., Olofsson P.S., Ochani M., Valdés-Ferrer S.I., Levine Y.A., Reardon C., Tusche M.W., Pavlov V.A., Andersson U., Chavan S., et al. Acetylcholine-synthesizing Tcells relay neural signals in a vagus nerve circuit. Science 2011, 334:98-101.
69. Sappington P.L., Yang R., Yang H., Tracey K.J., Delude R.L., Fink M.P. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 2002, 123:790-802.
70. Sarkar A., Hall M.W., Exline M., Hart J., Knatz N., Gatson N.T., Wewers M.D. Caspase-1 regulates Escherichia coli sepsis and splenic B cell apoptosis independently of interleukin-1beta and interleukin-18. Am. J. Respir. Crit. Care Med. 2006, 174:1003-1010.
71. Satapathy S.K., Ochani M., Dancho M., Hudson L.K., Rosas-Ballina M., Valdes-Ferrer S.I., Olofsson P.S., Harris Y.T., Roth J., Chavan S., et al. Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice. Mol. Med. 2011, 17:599-606.
72. Schroder K., Zhou R., Tschopp J. The NLRP3 inflammasome: asensor for metabolic danger?. Science 2010, 327:296-300.
73. Schwab J.M., Chiang N., Arita M., Serhan C.N. Resolvin E1 andprotectin D1 activate inflammation-resolution programmes. Nature 2007, 447:869-874.
74. Singer M. Mitochondrial function in sepsis: acute phase versus multiple organ failure. Crit. Care Med. 2007, 35(Suppl):S441-S448.
75. Singer M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence 2014, 5:66-72.
76. Stearns-Kurosawa D.J., Osuchowski M.F., Valentine C., Kurosawa S., Remick D.G. The pathogenesis of sepsis. Annu. Rev. Pathol. 2011, 6:19-48.
77. Stellwagen D., Malenka R.C. Synaptic scaling mediated by glial TNF-alpha. Nature 2006, 440:1054-1059.
78. Tang D., Kang R., Zeh H.J., Lotze M.T. High-mobility group box 1, oxidative stress, and disease. Antioxid. Redox Signal. 2011, 14:1315-1335.
79. Tannahill G.M., Curtis A.M., Adamik J., Palsson-McDermott E.M., McGettrick A.F., Goel G., Frezza C., Bernard N.J., Kelly B., Foley N.H., et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 2013, 496:238-242.
80. Thayer J.F. Vagal tone and the inflammatory reflex. Cleve. Clin. J. Med. 2009, 76(Suppl 2):S23-S26.
81. Thayer J.F., Lane R.D. Claude Bernard and the heart-brain connection: further elaboration of a model of neurovisceral integration. Neurosci. Biobehav. Rev. 2009, 33:81-88.
82. Thayer J.F., Sternberg E.M. Neural aspects of immunomodulation: focus on the vagus nerve. Brain Behav. Immun. 2010, 24:1223-1228.
83. Torres-Rosas R., Yehia G., Peña G., Mishra P., Del Rocio Thompson-Bonilla M., Moreno-Eutimio M.A., Arriaga-Pizano L.A., Isibasi A., Ulloa L. Dopamine mediates vagal modulation of the immune system by electroacupuncture. Nat. Med. 2014, 20:291-295.
84. Tracey K.J. The inflammatory reflex. Nature 2002, 420:853-859.
85. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J.Clin. Invest. 2007, 117:289-296.
86. Tracey K.J. Reflex control of immunity. Nat. Rev. Immunol. 2009, 9:418-428.
87. Tracey K.J., Beutler B., Lowry S.F., Merryweather J., Wolpe S., Milsark I.W., Hariri R.J., Fahey T.J., Zentella A., Albert J.D., et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986, 234:470-474.
88. Tracey K.J., Fong Y., Hesse D.G., Manogue K.R., Lee A.T., Kuo G.C., Lowry S.F., Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987, 330:662-664.
89. Ulloa L., Ochani M., Yang H., Tanovic M., Halperin D., Yang R., Czura C.J., Fink M.P., Tracey K.J. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc. Natl. Acad. Sci. USA 2002, 99:12351-12356.
90. Venereau E., Casalgrandi M., Schiraldi M., Antoine D.J., Cattaneo A., De Marchis F., Liu J., Antonelli A., Preti A., Raeli L., et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J.Exp. Med. 2012, 209:1519-1528.
91. Verma R., Huang Z., Deutschman C.S., Levy R.J. Caffeine restores myocardial cytochrome oxidase activity and improves cardiac function during sepsis. Crit. Care Med. 2009, 37:1397-1402.
92. Vincent J.-L., Opal S.M., Marshall J.C., Tracey K.J. Sepsis definitions: time for change. Lancet 2013, 381:774-775.
93. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
94. Wang H.H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Wang H., Yang H., Ulloa L., et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421:384-388.
95. Wang H.H., Liao H., Ochani M., Justiniani M., Lin X., Yang L., Al-Abed Y., Wang H., Metz C., Miller E.J., et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 2004, 10:1216-1221.
96. Wang H., Liao H., Ochani M., Justiniani M., Lin X., Hong L., Al-abed Y., Wang H., Metz C., Miller E.J., et al. Cholinergic Agonists Inhibit HMGB1 Release and Improve Survival in Established Severe Sepsis. Nat Med. 2004, 10:1216-1221.
97. Ward P.A., Bosmann M. A historical perspective on sepsis. Am. J. Pathol. 2012, 181:2-7.
98. Watkins L.R., Goehler L.E., Relton J.K., Tartaglia N., Silbert L., Martin D., Maier S.F. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci. Lett. 1995, 183:27-31.
99. Wen H., Ting J.P.-Y., O'Neill L.A. A role for the NLRP3 inflammasome in metabolic diseases-did Warburg miss inflammation?. Nat. Immunol. 2012, 13:352-357.
100. Werdan K., Schmidt H., Ebelt H., Zorn-Pauly K., Koidl B., Hoke R.S., Heinroth K., Müller-Werdan U. Impaired regulation of cardiac function in sepsis, SIRS, and MODS. Can. J. Physiol. Pharmacol. 2009, 87:266-274.
101. Wolfson R.K., Chiang E.T., Garcia J.G.N. HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption. Microvasc. Res. 2011, 81:189-197.
102. Wree A., Eguchi A., McGeough M.D., Pena C.A., Johnson C.D., Canbay A., Hoffman H.M., Feldstein A.E. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology 2014, 59:898-910.
103. Wu R., Dong W., Cui X., Zhou M., Simms H.H., Ravikumar T.S., Wang P. Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann. Surg. 2007, 245:480-486.
104. Wu R., Dong W., Qiang X., Wang H., Blau S.A., Ravikumar T.S., Wang P. Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats. Crit. Care Med. 2009, 37:2421-2426.
105. Yanai H., Ban T., Wang Z., Choi M.K., Kawamura T., Negishi H., Nakasato M., Lu Y., Hangai S., Koshiba R., et al. HMGB proteins function asuniversal sentinels for nucleic-acid-mediated innate immune responses. Nature 2009, 462:99-103.
106. Yanai H., Chiba S., Ban T., Nakaima Y., Onoe T., Ohdan H. Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs). Proc. Natl. Acad. Sci. U. 2011, 108:11542-11547.
107. Yanai H., Ban T., Taniguchi T. High-mobility group box family of proteins: ligand and sensor for innate immunity. Trends Immunol. 2012, 33:633-640.
108. Yang H., Ochani M., Li J., Qiang X., Tanovic M., Harris H.E., Susarla S.M., Ulloa L., Wang H.H., DiRaimo R., et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. USA 2004, 101:296-301.
109. Yang R., Harada T., Mollen K.P., Prince J.M., Levy R.M., Englert J.A., Gallowitsch-Puerta M., Yang L., Yang H., Tracey K.J., et al. Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol. Med. 2006, 12:105-114.
110. Yang H., Lundbäck P., Ottosson L., Erlandsson-Harris H., Venereau E., Bianchi M.E., Al-Abed Y., Andersson U., Tracey K.J., Antoine D.J. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol. Med. 2012, 18:250-259.
111. Ye C., Choi J.-G., Abraham S., Wu H., Diaz D., Terreros D., Shankar P., Manjunath N. Human macrophage and dendritic cell-specific silencing of high-mobility group protein B1 ameliorates sepsis in a humanized mouse model. Proc. Natl. Acad. Sci. USA 2012, 109:21052-21057.
112. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., Brohi K., Itagaki K., Hauser C.J. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107.